STREAMEX CORP. Cost of Revenue
STREAMEX CORP. (STEX) reported Cost of Revenue of $57.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-16.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2024-04-16
- STREAMEX CORP. cost of goods and services sold for the quarter ending 2022-12-31 was $27.00K.
- STREAMEX CORP. cost of goods and services sold for the quarter ending 2022-09-30 was $30.00K, a 21.05% decline year-over-year.
- STREAMEX CORP. cost of goods and services sold for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- STREAMEX CORP. cost of goods and services sold for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- STREAMEX CORP. cost of goods and services sold for fiscal 2022 was $57.00K, a 71.36% decline from fiscal 2021.
- STREAMEX CORP. cost of goods and services sold for fiscal 2021 was $199.00K.
- STREAMEX CORP. cost of goods and services sold for fiscal 2020 was $0.00.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2022-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $57.00K derived: sum of 2 quarters · filed 2024-04-16 | $57.00K derived: sum of 3 quarters · filed 2024-04-16 | $57.00K 10-K · filed 2024-04-16 |
| 2022-09-30 | $30.00K 10-Q · filed 2023-11-14 | $30.00K derived: sum of 2 quarters · filed 2023-11-14 | $30.00K 10-Q · filed 2023-11-14 | $30.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $38.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $38.00K derived: sum of 3 quarters · filed 2023-03-31 | $100.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $38.00K derived: sum of 2 quarters · filed 2023-03-31 | $100.00K derived: sum of 3 quarters · filed 2023-03-31 | $199.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $38.00K 10-Q · filed 2022-11-14 | $100.00K derived: sum of 2 quarters · filed 2022-11-14 | $199.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $62.00K 10-Q · filed 2022-08-15 | $161.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $99.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |